发明名称 |
Glycosylation-mediated inhibition of factor X |
摘要 |
Reagents that specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an alpha 2-6 linkage are able to inhibit the conversion of human Factor X to human Factor Xa. These reagents (SA/Gal/GalNAc binding reagents) as well as other strategies for inhibiting the conversion of Factor X to Factor Xa are useful in treating thrombosis, inflammation and other conditions associated with excess thrombin activity.
|
申请公布号 |
US5798332(A) |
申请公布日期 |
1998.08.25 |
申请号 |
US19940302226 |
申请日期 |
1994.09.06 |
申请人 |
COR THERAPEUTICS, INC. |
发明人 |
SINHA, UMA;WOLF, DAVID L. |
分类号 |
A61K38/36;A61K38/00;A61K38/17;A61K38/43;A61K38/47;A61K39/395;A61P7/02;A61P29/00;C07K14/42;C07K14/745;C07K16/36;C12N9/64;(IPC1-7):A61K38/16 |
主分类号 |
A61K38/36 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|